AlloVir Announces Oral Data Presentations at 62nd American Society of Hematology Annual Meeting
04 nov. 2020 13h33 HE
|
AlloVir Inc.
CAMBRIDGE, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced that it will present three abstracts as oral presentations that...
AlloVir Reports Second Quarter 2020 Financial Results
02 sept. 2020 07h30 HE
|
AlloVir Inc.
CAMBRIDGE, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, today reported financial results for the second quarter ended June 30, 2020. ...